AI Verdict
ABBV has stronger fundamentals based on our AI analysis.
ABBV vs BAX Fundamental Comparison
| Metric | ABBV | BAX |
|---|---|---|
| Revenue | $61.2B | $11.2B |
| Net Income | $4.2B | $-957.0M |
| Net Margin | 6.9% | -8.5% |
| ROE | N/A | -15.6% |
| ROA | 3.2% | -4.8% |
| Current Ratio | 0.67x | 2.31x |
| Debt/Equity | N/A | 1.54x |
| EPS | $2.36 | $-1.87 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ABBV vs BAX: Frequently Asked Questions
Is ABBV or BAX a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), ABBV has stronger fundamentals. ABBV is rated HOLD (70% confidence) while BAX is rated SELL (80% confidence). This is not investment advice.
How does ABBV compare to BAX fundamentally?
AbbVie Inc. has ROE of N/A vs BAXTER INTERNATIONAL INC's -15.6%. Net margins are 6.9% vs -8.5% respectively.
Which stock pays higher dividends, ABBV or BAX?
ABBV has a dividend yield of N/A or no dividend while BAX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ABBV or BAX for long term?
For long-term investing, consider that ABBV has HOLD rating with 70% confidence, while BAX has SELL rating with 80% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ABBV vs BAX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ABBV vs BAX, the AI consensus favors ABBV based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.